HIC
BIIB icon

Holderness Investments Company’s Biogen BIIB Stock Holding History

Holderness Investments Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,134
Closed -$265K – 181
2019
Q2 		$265K Buy
1,134
+4
+0.4% +$924 0.12% 161
2019
Q1 		$267K Sell
1,130
-5
-0.4% -$1.57K 0.13% 152
2018
Q4 		$342K Buy
1,135
+75
+7% +$23.9K 0.19% 122
2018
Q3 		$375K Hold
1,060
– – 0.17% 139
2018
Q2 		$308K Buy
1,060
+33
+3% +$9.28K 0.15% 149
2018
Q1 		$281K Buy
1,027
+57
+6% +$17.7K 0.14% 156
2017
Q4 		$309K Hold
970
– – 0.15% 152
2017
Q3 		$304K Hold
970
– – 0.16% 149
2017
Q2 		$263K Sell
970
-45
-4% -$11.9K 0.14% 163
2017
Q1 		$278K Buy
+1,015
New +$287K 0.14% 159

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Holderness Investments Company's BIIB Position: Q3 2019 in Review

Holderness Investments Company sold out of Biogen (BIIB) in Q3 2019, closing a stake of 1,134 shares — an estimated $265K sold.

Holderness Investments Company first reported a position in BIIB in Q1 2017 and held it in 10 quarters. The position peaked at $375K in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Holderness Investments Company reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Holderness Investments Company sold 1,134 Biogen shares in Q3 2019, an estimated $265K.
  • Holderness Investments Company first reported a position in Biogen in Q1 2017 and held it in 10 quarters.
  • Holderness Investments Company's Biogen position peaked at $375K in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Holderness Investments Company's 13F filing for Q3 2019, filed 1 Nov 2019.